The power of artificial intelligence (AI) to find out novel senolytic compounds, a class of small molecules under intense study for their potential to suppress age-related processes like inflammation, fibrosis, and cancer has been illustrated.
The team from the Massachusetts Institute of Technology (MIT) and the Broad Institute of MIT and Harvard, described the AI-guided screening of more than 800,000 compounds to reveal three drug candidates with comparable efficacy and superior medicinal chemistry properties than those currently under investigation.
Artificial intelligence (AI)- guided screening has identified three anti-aging drug candidates targeting 'zombie' cells, a significant milestone for both longevity research and the application of AI in drug discovery, researchers revealed.The .
The team from the Massachusetts Institute of Technology (MIT) and the Broad Institute of MIT and Harvard, described the AI-guided screening of more than 800,000 compounds to reveal three drug candidates with comparable efficacy and superior medicinal chemistry properties than those currently under investigation.
AI-Discovered Meds Show Promise in Slowing Aging scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.